Fentanyl-Based Induction Guidelines

Dosing Recommendations

The recommended starting dose for fentanyl-based induction is 50-100 μg intravenously, with supplemental doses of 25 μg administered every 2-5 minutes until adequate sedation is achieved, as recommended by the American Gastroenterological Association 1
For healthy adults, the initial intravenous dose is 50-100 μg, titrated to effect, according to the American Gastroenterological Association 2, 1
For elderly patients, a dose reduction of 50% or more is indicated (25-50 μg initially), as suggested by the American Gastroenterological Association 2, 1
For patients receiving continuous fentanyl infusions who develop breakthrough pain or respiratory distress, a bolus dose equal to the hourly infusion rate should be administered every 5 minutes as needed, as recommended by the Society of Critical Care Medicine 3, 4

Onset of action after IV administration is 1-2 minutes, with peak effect at 3-4 minutes, according to the American Gastroenterological Association 2, 1
Duration of effect is 30-60 minutes, though respiratory depression may persist longer than the analgesic effect, as noted by the American Gastroenterological Association 1
Continuous monitoring of respiratory status and vital signs is essential during fentanyl induction, as recommended by the American Gastroenterological Association 2
Patients receiving naloxone to reverse fentanyl effects should be monitored for up to 2 hours due to the possibility of renarcotization, according to the American Gastroenterological Association 1

Fentanyl should be titrated to symptoms with no specified dose limit during withdrawal of life-sustaining measures, as recommended by the Society of Critical Care Medicine 3, 4
For opioid-naïve patients requiring pain management during end-of-life care, morphine is the initial opioid of choice rather than fentanyl, according to the Society of Critical Care Medicine 4
The major adverse effect of fentanyl is respiratory depression, which may persist longer than the analgesic effect, as noted by the American Gastroenterological Association 1
The concomitant use of benzodiazepines with fentanyl has a synergistic effect on the risk of respiratory depression, according to the American Gastroenterological Association 2, 1

When converting from other opioids to fentanyl, use established equianalgesic conversion tables to determine appropriate dosing, as recommended by the National Comprehensive Cancer Network 5

Failing to reduce the dose appropriately in elderly patients or those with hepatic or renal impairment, as noted by the American Gastroenterological Association 2, 1
Not accounting for the synergistic effects when combining fentanyl with benzodiazepines or other sedatives, according to the American Gastroenterological Association 2, 1